Loading...
XNYS
JNJ
Market cap623bUSD
Oct 20, Last price  
258.52USD
1D
2.19%
1Q
1.46%
Jan 2017
125.12%
Name

Johnson & Johnson

Chart & performance

D1W1MN
XNYS:JNJ chart
P/E
23.24
P/S
6.61
EPS
11.12
Vol. 1Y
20.46%
Shs. 5Y
-1.88%
Rev. 5Y
2.67%
Div Yld LY
1.99%
Div Yld TTM
2.04%
Revenues
94.19b
+6.05%
67,224,000,00071,312,000,00071,312,000,00074,331,000,00074,331,000,00070,074,000,00070,074,000,00071,890,000,00071,890,000,00076,450,000,00081,581,000,00081,581,000,00082,059,000,00082,059,000,00082,584,000,00078,740,000,00079,990,000,00085,159,000,00088,821,000,00094,193,000,000
Net income
26.80b
+90.56%
10,853,000,00013,831,000,00013,831,000,00016,323,000,00016,323,000,00015,409,000,00015,409,000,00016,540,000,00016,540,000,0001,300,000,00015,297,000,00015,297,000,00015,119,000,00015,119,000,00014,714,000,00020,878,000,00017,941,000,00035,153,000,00014,066,000,00026,804,000,000
CFO
24.53b
+1.09%
15,396,000,00017,414,000,00017,414,000,00018,471,000,00018,471,000,00019,279,000,00019,279,000,00018,767,000,00018,767,000,00021,056,000,00022,201,000,00022,201,000,00023,416,000,00023,416,000,00023,536,000,00023,410,000,00021,194,000,00022,791,000,00024,266,000,00024,530,000,000
Dividend
Nov 24, 20261.34 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Johnson & Johnson functions as a global healthcare enterprise, involved in the research, development, manufacturing, and commercialization of a wide spectrum of health-related products. Its activities are organized across three principal divisions: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment provides an extensive range of goods, encompassing baby care items under brands like JOHNSON'S and AVEENO Baby, oral hygiene products such as LISTERINE, and skin/beauty solutions from AVEENO, NEUTROGENA, and OGX. It also offers over-the-counter medications for various ailments, including pain relief (TYLENOL, MOTRIN IB), cold, flu, and allergy symptoms (SUDAFED, BENADRYL, ZYRTEC), smoking cessation aids (NICORETTE), and acid reflux treatments (PEPCID). Additionally, this division includes women's health products like STAYFREE and o.b., wound care essentials such as BAND-AID adhesive bandages, and NEOSPORIN for first aid. The Pharmaceutical segment is dedicated to developing therapies within significant therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic disorders. The Medical Devices segment delivers sophisticated solutions for cardiovascular conditions, including electrophysiology and neurovascular care for strokes. It also provides orthopaedic products supporting hips, knees, trauma, spine, and sports-related needs, alongside advanced and general surgical solutions focusing on breast aesthetics and ear, nose, and throat procedures. Furthermore, this segment offers ophthalmic products, notably ACUVUE brand disposable contact lenses and technologies for cataract and laser refractive surgery. The company distributes its products through diverse channels, reaching the general public via retail outlets and distributors, and directly supplying wholesalers, hospitals, and healthcare professionals for prescription-based use. Johnson & Johnson was established in 1886 and maintains its headquarters in New Brunswick, New Jersey.

Related entities

Subsidiaries (205)
ACCLARENT, INC.
ACTELION PHARMACEUTICALS US, INC.
ACTELION TREASURY UNLIMITED COMPANY
ALZA CORPORATION
AMO (HANGZHOU) CO., LTD.
AMO ASIA LIMITED
AMO HOLDINGS, INC.
AMO SALES AND SERVICE, INC.
AURIS HEALTH, INC.
BEIJING DABAO COSMETICS CO., LTD.
BIOMEDICAL ENTERPRISES, INC.
Biosense Webster (Israel) Ltd.
BIOSENSE WEBSTER, INC.
Cilag Holding AG
CORDIS FINANCING CORPORATION
DEPUY SYNTHES PRODUCTS, INC.
DEPUY SYNTHES SALES, INC.
DEPUY SYNTHES, INC.
ETHICON ENDO-SURGERY (EUROPE) GMBH
ETHICON ENDO-SURGERY, INC.

Key people

Chairman of the Board, Chief Executive Officer · since 2023
Chief Financial Officer, Executive Vice President · since 2018
Executive Vice President - Global Corporate Affairs · since 2022
Elizabeth Forminard
Executive Vice President, Chief Legal Officer · since 2022
Kristen Mulholland
Chief Human Resources Officer, Executive Vice President · since 2024
John Reed
Executive Vice President - Innovative Medicine, Research and Development · since 2023
Tim Schmid
Executive Vice President, Worldwide Chairman of MedTech · since 2023
James Swanson
Executive Vice President, Chief Information Officer · since 2022
Executive Vice President, Worldwide Chairman, Innovative Medicine · since 2018
Executive Vice President, Chief Technology Officer and Risk Officer · since 2023
Lead Independent Director · since 2024
Darius Adamczyk
Independent Director · since 2022
Independent Director · since 2015
Jennifer Doudna
Independent Director · since 2018
Independent Director · since 2023
Independent Director · since 2019
Independent Director · since 2013
Independent Director · since 2025
Independent Director · since 2024
Independent Director · since 2019
IPO date
Sep 25, 1944
Employees
152,700
Domiciled in
US
Incorporated in
US
Headquarters & legal address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑002021‑002019‑122019‑122018‑122018‑122017‑122017‑002016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT